Cough News and Research

RSS

Coartem tablets approved in U.S. to treat malaria

The U.S. Food and Drug Administration has approved Coartem tablets (artemether and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least five kilograms (approximately 11 pounds).

8 Apr 2009

A person's waist size is a predictor of heart health

Adding to the growing evidence that a person's waist size is an important indicator of heart health, a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has found that larger waist circumference is associated with increased risk of heart failure in middle-aged and older populations of men and women.

8 Apr 2009

FDA approves new indication for Wyeth's Tygacil (tigecycline)

Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration (FDA) approved Tygacil (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.

24 Mar 2009

Ultraviolet light cuts spread of tuberculosis

Ultraviolet lights could reduce the spread of tuberculosis in hospital wards and waiting rooms by 70%, according to a new study, published in PLoS Medicine today.

16 Mar 2009

Obama nominates former New York City health chief Hamburg as FDA commissioner, Baltimore Health Commissioner Sharfstein as Deputy

President Obama in his weekly radio and Internet address on Saturday said that he would nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner and Baltimore Health Commissioner Joshua Sharfstein as the agency's principal deputy commissioner, the New York Times reports (Harris, New York Times, 3/15).

16 Mar 2009

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients with lupus nephritis did not meet its primary endpoint of significantly reducing disease activity at 52 weeks.

11 Mar 2009

Drug combo shows potential for treating extensively drug resistant tuberculosis

A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.

26 Feb 2009

Magnetic device studied as treatment for heartburn and acid reflux

More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.

23 Feb 2009

Study examines the effects of indoor particulate matter pollution on asthma in children

A study by researchers at Johns Hopkins University found an association between increasing levels of indoor particulate matter pollution and the severity of asthma symptoms among children.

20 Feb 2009

U.S. Court of Federal Claims declares vaccines do not cause autism

The three judges ruled that the measles-mumps-rubella vaccine (MMR), given in combination with thimerosal-containing vaccines, does not cause autism.

17 Feb 2009

5-in-1 combo vaccine increases on-time immunization in children

A "5-in-1" combination vaccine increases the percentage of children receiving all recommended vaccinations at the scheduled time, reports a study in the February issue of The Pediatric Infectious Disease Journal.

11 Feb 2009

Fluid buildup in lungs is part of the damage done by the flu

In a fight against respiratory infections, the body typically produces a little fluid to help the lungs generate a productive cough.

10 Feb 2009

New vaccine developed for preventing human adenovirus type-3d virus

Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind.

2 Feb 2009

Non-surgical, non-pharmacological treatments for gastroesophageal reflux disease compared

Two non-surgical, non-pharmacological treatments for gastroesophageal reflux disease (GERD) both appear effective in reducing medication use and improving voice and swallowing symptoms, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.

19 Jan 2009

Cough News and Research

Coartem tablets approved in U.S. to treat malaria

A person's waist size is a predictor of heart health

FDA approves new indication for Wyeth's Tygacil (tigecycline)

Ultraviolet light cuts spread of tuberculosis

Obama nominates former New York City health chief Hamburg as FDA commissioner, Baltimore Health Commissioner Sharfstein as Deputy

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Drug combo shows potential for treating extensively drug resistant tuberculosis

Magnetic device studied as treatment for heartburn and acid reflux

Study examines the effects of indoor particulate matter pollution on asthma in children

U.S. Court of Federal Claims declares vaccines do not cause autism

5-in-1 combo vaccine increases on-time immunization in children

Fluid buildup in lungs is part of the damage done by the flu

New vaccine developed for preventing human adenovirus type-3d virus

Non-surgical, non-pharmacological treatments for gastroesophageal reflux disease compared

Vicks VapoRub may create respiratory distress in young children

Warning about Vicks VapoRub

Discovery of novel ways to halt the spread of antibiotic resistance

Genetic mutation causes familial susceptibility for degenerative brain disease acute necrotizing encephalopathy

Antibodies take 'evolutionary leaps' to fight microbes

Brits battling to cope with 'killer' Australian flu strain

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News